Ensuring equitable access to these effective but high-cost medications, as well as supporting individuals so that they can stay on the therapy long-term, should be a priority for our clinicians and policymakers. The findings, which were presented at the American Heart Association Scientific Sessions and simultaneously published in JAMA Cardiology, underscore the need to increase equitable access to this new class of pharmaceuticals
What is the maximum semaglutide dose approved by the FDA
Prime Day is here again and Amazons subscription service has never been more popular Well, its that time of year again: many have made their wish lists, people are scraping together the money theyve saved to pick out a perfect gift, some are presumably leaving out refreshments for the weary delivery drivers and, more and more, drones
Diagnostics (Basel, Switzerland), 13 (20), 3172